MAM
PRAX icon

Martingale Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Martingale Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,615
Closed -$520K – 878
2026
Q1 		$520K Buy
1,615
+559
+53% +$173K 0.01% 626
2025
Q4 		$311K Buy
+1,056
New +$197K 0.01% 693

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Martingale Asset Management's PRAX Position: Q2 2026 in Review

Martingale Asset Management sold out of Praxis Precision Medicines (PRAX) in Q2 2026, closing a stake of 1,615 shares — an estimated $520K sold.

Martingale Asset Management first reported a position in PRAX in Q4 2025 and held it in 2 quarters. The position peaked at $520K in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Martingale Asset Management reported no remaining Praxis Precision Medicines position as of Q2 2026 after selling out during the quarter.
  • Martingale Asset Management sold 1,615 Praxis Precision Medicines shares in Q2 2026, an estimated $520K.
  • Martingale Asset Management first reported a position in Praxis Precision Medicines in Q4 2025 and held it in 2 quarters.
  • Martingale Asset Management's Praxis Precision Medicines position peaked at $520K in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.